In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Three Questions for Biotech

Executive Summary

When the market returns to steady-state, following its current valuation gyrations, we'd like to see biotechs answer three basic questions. Who will be the new financiers of the biotech industry--investors or pharma? How will biotechs show they can increase their market value at competitive rates off already high valuations? How will the biotech industry handle its public image--particularly as genomics becomes a consumer issue?

You may also be interested in...



Some Annex XVI Products Likely To Be Delayed, Latest Commission Updated Rolling Plan Suggests

The European Commission has updated its rolling plan. It now looks as if current member state rules for non-medical products could persist beyond the 26 May 2021 deadline.

GSK Tapping Into Naturals Trend With UK Piri Extension

GSK launches a 100% natural saline spray in the UK to compliment its Piri hayfever brand portfolio.

Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal

Progress for two US-based companies in the race to develop a COVID-19 vaccine.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

AP014275

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel